Literature DB >> 20145170

Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.

Mala Pande1, Patrick M Lynch, John L Hopper, Mark A Jenkins, Steve Gallinger, Robert W Haile, Loic LeMarchand, Noralane M Lindor, Peter T Campbell, Polly A Newcomb, John D Potter, John A Baron, Marsha L Frazier, Christopher I Amos.   

Abstract

PURPOSE: Lynch syndrome family members with inherited germline mutations in DNA mismatch repair (MMR) genes have a high risk of colorectal cancer (CRC), and cases typically have tumors that exhibit a high level of microsatellite instability (MSI). There is some evidence that smoking is a risk factor for CRCs with high MSI; however, the association of smoking with CRC among those with Lynch syndrome is unknown. EXPERIMENTAL
DESIGN: A multicentered retrospective cohort of 752 carriers of pathogenic MMR gene mutations was analyzed, using a weighted Cox regression analysis, adjusting for sex, ascertainment source, the specific mutated gene, year of birth, and familial clustering.
RESULTS: Compared with never smokers, current smokers had a significantly increased CRC risk [adjusted hazard ratio (HR), 1.62; 95% confidence interval (95% CI), 1.01-2.57] and former smokers who had quit smoking for 2 or more years were at decreased risk (HR, 0.53; 95% CI, 0.35-0.82). CRC risk did not vary according to age at starting. However, light smoking (<10 cigarettes per day) and shorter duration of smoking (<10 years) were associated with decreased CRC risk (HR, 0.51; 95% CI, 0.29-0.91 and HR, 0.52; 95% CI, 0.30-0.89, respectively). For former smokers, CRC risk decreased with years since quitting (P trend <0.01).
CONCLUSIONS: People with Lynch syndrome may be at increased risk of CRC if they smoke regularly. Although our data suggest that former smokers, short-term smokers, and light smokers are at decreased CRC risk, these findings need further confirmation, preferably using prospective designs.

Entities:  

Mesh:

Year:  2010        PMID: 20145170      PMCID: PMC2822883          DOI: 10.1158/1078-0432.CCR-09-1877

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  34 in total

Review 1.  At the interfaces of epidemiology, genetics and genomics.

Authors:  J D Potter
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

2.  A note on robust variance estimation for cluster-correlated data.

Authors:  R L Williams
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

Review 3.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 4.  An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer.

Authors:  E Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-07       Impact factor: 4.254

5.  Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.

Authors:  M L Frazier; F T O'Donnell; S Kong; X Gu; I Campos; R Luthra; P M Lynch; C I Amos
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Family history and colorectal cancer: predictors of risk.

Authors:  M L Slattery; T R Levin; K Ma; D Goldgar; R Holubkov; S Edwards
Journal:  Cancer Causes Control       Date:  2003-11       Impact factor: 2.506

7.  Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.

Authors:  Mala Pande; Christopher I Amos; Daniel R Osterwisch; Jinyun Chen; Patrick M Lynch; Russell Broaddus; Marsha L Frazier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

9.  BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Authors:  E Domingo; P Laiho; M Ollikainen; M Pinto; L Wang; A J French; J Westra; T Frebourg; E Espín; M Armengol; R Hamelin; H Yamamoto; R M W Hofstra; R Seruca; A Lindblom; P Peltomäki; S N Thibodeau; L A Aaltonen; S Schwartz
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

10.  Smoking and the risk of breast cancer among carriers of BRCA mutations.

Authors:  Parviz Ghadirian; Jan Lubinski; Henry Lynch; Susan L Neuhausen; Barbara Weber; Claudine Isaacs; Ruth-Gershoni Baruch; Susan Randall; Peter Ainsworth; Eitan Friedman; Eitan Freidman; Douglas Horsman; Patricia Tonin; William D Foulkes; Nadine Tung; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2004-06-20       Impact factor: 7.396

View more
  25 in total

1.  Plasma levels of resistin-like molecule beta in humans.

Authors:  Andrew P Neilson; Zora Djuric; Susan Land; Ikuko Kato
Journal:  Cancer Epidemiol       Date:  2010-11-19       Impact factor: 2.984

Review 2.  Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?

Authors:  Fränzel J B van Duijnhoven; Akke Botma; Renate Winkels; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

3.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?

Authors:  Aung Ko Win; John L Hopper; Daniel D Buchanan; Joanne P Young; Albert Tenesa; James G Dowty; Graham G Giles; Jack Goldblatt; Ingrid Winship; Alex Boussioutas; Graeme P Young; Susan Parry; John A Baron; David Duggan; Steven Gallinger; Polly A Newcomb; Robert W Haile; Loïc Le Marchand; Noralane M Lindor; Mark A Jenkins
Journal:  Eur J Cancer       Date:  2013-02-22       Impact factor: 9.162

4.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors:  Mark A Jenkins; Aung Ko Win; Allyson S Templeton; Maggie S Angelakos; Daniel D Buchanan; Michelle Cotterchio; Jane C Figueiredo; Stephen N Thibodeau; John A Baron; John D Potter; John L Hopper; Graham Casey; Steven Gallinger; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Robert W Haile
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

5.  Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Masashi Miguchi; Takao Hinoi; Kohji Tanakaya; Tatsuro Yamaguchi; Yoichi Furukawa; Teruhiko Yoshida; Kazuo Tamura; Kokichi Sugano; Chikashi Ishioka; Nagahide Matsubara; Naohiro Tomita; Masami Arai; Hideki Ishikawa; Keiji Hirata; Yoshihisa Saida; Hideyuki Ishida; Kenichi Sugihara
Journal:  Surg Today       Date:  2018-03-24       Impact factor: 2.549

6.  [Incidence of Colon Cancer Related to Cigarette Smoking and Alcohol Consumption in Adults with Metabolic Syndrome: Prospective Cohort Study].

Authors:  Ahra Jo; Heeyoung Oh
Journal:  J Korean Acad Nurs       Date:  2019-12       Impact factor: 0.984

7.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Authors:  Driss Ait Ouakrim; Seyedeh Ghazaleh Dashti; Rowena Chau; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Joanne P Young; Graham G Giles; Barbara Leggett; Finlay A Macrae; Dennis J Ahnen; Graham Casey; Steven Gallinger; Robert W Haile; Loïc Le Marchand; Stephen N Thibodeau; Noralane M Lindor; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  J Natl Cancer Inst       Date:  2015-06-24       Impact factor: 13.506

8.  The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Authors:  Joanne Soo-Min Kim; Peter C Coyte; Michelle Cotterchio; Louise A Keogh; Louisa B Flander; Clara Gaff; Audrey Laporte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

9.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

10.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Authors:  Rowena Chau; Seyedeh Ghazaleh Dashti; Driss Ait Ouakrim; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Joanne P Young; Graham G Giles; Finlay A Macrae; Alex Boussioutas; Susan Parry; Jane C Figueiredo; A Joan Levine; Dennis J Ahnen; Graham Casey; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Stephen N Thibodeau; Noralane M Lindor; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  Int J Epidemiol       Date:  2016-04-10       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.